Bregman N - Search Results

1

Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.

Thaler A, Kliper E, Maidan I, Herman T, Rosenberg-Katz K, Bregman N, Gurevich T, Shiner T, Hausdorff JM, Orr-Urtreger A, Giladi N, Mirelman A. Thaler A, et al. Among authors: bregman n. Brain Topogr. 2018 Nov;31(6):1029-1036. doi: 10.1007/s10548-018-0653-8. Epub 2018 May 30. Brain Topogr. 2018. PMID: 29846835

2

A Simple Tool to Reach Populations at Risk for Developing Dementia and Alzheimer's Disease.

Bregman N, Regev K, Moore O, Giladi N, Ash E. Bregman N, et al. J Alzheimers Dis. 2015;46(1):151-5. doi: 10.3233/JAD-142724. J Alzheimers Dis. 2015. PMID: 25720401

3

A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.

Bregman N, Thaler A, Mirelman A, Helmich RC, Gurevich T, Orr-Urtreger A, Marder K, Bressman S, Bloem BR, Giladi N; LRRK2 Ashkenazi Jewish consortium. Bregman N, et al. Brain Struct Funct. 2017 Apr;222(3):1207-1218. doi: 10.1007/s00429-016-1271-4. Epub 2016 Jul 11. Brain Struct Funct. 2017. PMID: 27401793

4

High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.

Shiner T, Mirelman A, Gana Weisz M, Bar-Shira A, Ash E, Cialic R, Nevler N, Gurevich T, Bregman N, Orr-Urtreger A, Giladi N. Shiner T, et al. Among authors: bregman n. JAMA Neurol. 2016 Dec 1;73(12):1448-1453. doi: 10.1001/jamaneurol.2016.1593. JAMA Neurol. 2016. PMID: 27723861

5

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.

Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O, Gan-Or Z, Bar-Shira A, Gana-Weisz M, Orr-Urtreger A, Giladi N, Mirelman A. Thaler A, et al. Among authors: bregman n. Parkinsonism Relat Disord. 2018 Oct;55:45-49. doi: 10.1016/j.parkreldis.2018.05.009. Epub 2018 May 17. Parkinsonism Relat Disord. 2018. PMID: 29784561

6

Dissociation in awareness of memory and language decline in Alzheimer's disease.

Bregman N, Kavé G, Shiner T, Biran I; Alzheimer's Disease Neuroimaging Initiative. Bregman N, et al. Int J Geriatr Psychiatry. 2019 Apr;34(4):548-554. doi: 10.1002/gps.5049. Epub 2018 Dec 21. Int J Geriatr Psychiatry. 2019. PMID: 30548691

7

Distinguishing Dementia With Lewy Bodies From Alzheimer Disease: What is the Influence of the GBA Genotype in Ashkenazi Jews?

Bregman N, Kavé G, Mirelman A, Thaler A, Gana Weisz M, Bar-Shira A, Orr-Urtreger A, Giladi N, Shiner T. Bregman N, et al. Alzheimer Dis Assoc Disord. 2019 Jul-Sep;33(3):279-281. doi: 10.1097/WAD.0000000000000283. Alzheimer Dis Assoc Disord. 2019. PMID: 30640255

8

Differential changes in visual and auditory event-related oscillations in dementia with Lewy bodies.

Rosenblum Y, Maidan I, Fahoum F, Giladi N, Bregman N, Shiner T, Mirelman A. Rosenblum Y, et al. Among authors: bregman n. Clin Neurophysiol. 2020 Oct;131(10):2357-2366. doi: 10.1016/j.clinph.2020.06.029. Epub 2020 Jul 23. Clin Neurophysiol. 2020. PMID: 32828038

9

The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews.

Shiner T, Mirelman A, Rosenblum Y, Kavé G, Weisz MG, Bar-Shira A, Goldstein O, Thaler A, Gurevich T, Orr-Urtreger A, Giladi N, Bregman N. Shiner T, et al. Among authors: bregman n. J Alzheimers Dis. 2021;80(3):1221-1229. doi: 10.3233/JAD-201295. J Alzheimers Dis. 2021. PMID: 33646158 Free PMC article.

10

On the importance of using local tests and local norms in the assessment of memory.

Kavé G, Sapir-Yogev S, Bregman N, Shiner T. Kavé G, et al. Among authors: bregman n. Appl Neuropsychol Adult. 2022 Nov-Dec;29(6):1492-1498. doi: 10.1080/23279095.2021.1892677. Epub 2021 Mar 11. Appl Neuropsychol Adult. 2022. PMID: 33691536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page